BioSpace News Archive

Drug Development

Biopharma Industry News for March 24: Update on the Novel Coronavirus

A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.

March 24, 2020
·
4 min read
·
BioSpace Editorial Staff
Business

Roche CEO: Broad Testing for COVID-19 Could Take “Weeks, If Not Months”

“The industry is increasing capacities, but at the same time infection rates are even increasing faster,” said Roche CEO Severin Schwan. “At the moment, capacities are limited. That is why we have to prioritize testing to higher risk patients.”

March 24, 2020
·
4 min read
·
Mark Terry
Business

New York Launches Coronavirus Plasma Trial with Undisclosed Pharma Partner

To combat the growing number of cases, the state is pulling out the stops in testing the use of antibodies from the plasma of recovered COVID-19 patients.

March 24, 2020
·
2 min read
·
Alex Keown
Business

Astellas and CytomX Strike Immuno-Oncology Deal Worth More than $1.6 Billion

Under terms of the agreement, Astellas will make an upfront cash payment of $80 million to CytomX.

March 24, 2020
·
2 min read
·
Alex Keown
FDA

Pfizer Wins New Pediatric Approval for Atopic Dermatitis Ointment Eucrisa

The ointment had previously been approved for patients ages two and above in 2016.

March 24, 2020
·
2 min read
·
Alex Keown
Business

How Life Sciences Labs and Companies Prepped for Mandatory Stay-at-Home Orders

Organizations should plan for the worst and hope for the best, ensuring critical research can be continued without risking the safety of employees or the continuity of the company.

March 24, 2020
·
3 min read
·
Gail Dutton
BioCapital

Research Groups Suggest COVID-19 Could Be Seasonal

Four separate research groups in the U.S., Australia and China analyzed how temperature and humidity affect the coronavirus and they predict that hot summer months could decrease the presence of the virus in the Northern Hemisphere.

March 24, 2020
·
4 min read
·
Mark Terry
Business

Rocket Pharmaceuticals’ Clinical Programs on Track Despite Adjustments for Pandemic

Rocket Pharmaceuticals CEO Gaurav Shah said the remote-working policies that have resulted from the global COVID-19 pandemic have created a challenging time for the pharmaceutical industry, as well as the rest of the global community, but believes a silver lining will be forthcoming.

March 24, 2020
·
3 min read
·
Alex Keown
7 Positive Professional Skills You Can Learn From a Bad Job

Not every job will be good for you but one thing is sure each will help you learn some skills. Here are seven positive professional skills you can learn from a bad job!

March 24, 2020
·
4 min read
·
Porschia Parker-Griffin
Genome Editing Market – Key Players Strategies Analysis Study

Also known as genome editing with engineered nucleases, genome editing is a method of altering DNA within a cell in a safe manner.

March 24, 2020
·
4 min read